Zollinger-Ellison syndrome ultrasound

Jump to navigation Jump to search

Zollinger-Ellison syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Zollinger-Ellison syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Zollinger-Ellison syndrome ultrasound On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Zollinger-Ellison syndrome ultrasound

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Zollinger-Ellison syndrome ultrasound

CDC on Zollinger-Ellison syndrome ultrasound

Zollinger-Ellison syndrome ultrasound in the news

Blogs on Zollinger-Ellison syndrome ultrasound

Directions to Hospitals Treating Zollinger-Ellison syndrome

Risk calculators and risk factors for Zollinger-Ellison syndrome ultrasound

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Abdominal ultrasound may be helpful in the diagnosis of Zollinger-Ellison syndrome caused by gastrinoma.[1]. Ultrasonography can detect gastrinomas in 30%. Endoscopic ultrasonography (EUS) is a highly sensitive and specific procedure for the localization of pancreatic endocrine tumors and duodenal as well as pancreatic gastrinomas.

Abdominal Ultrasound

  • Ultrasonography can detect gastrinomas in 30% of cases and the detection rates are better for lesions greater than 3 cm in diameter and are poor for lesions smaller than 1 cm. [2]
  • Endoscopic ultrasonography (EUS) is a highly sensitive and specific procedure for the localization of pancreatic endocrine tumors and should be considered for the preoperative localization of such tumors once the clinical and laboratory diagnosis has been established. [3]
  • When a gastrinoma is suspected, endoscopy or EUS should also be performed to identify duodenal as well as pancreatic gastrinomas, especially when multiple lesions are suspected as in MEN 1. [4] [5]

References

  1. Harvey, Adrian; Pasieka, Janice L.; Al-Bisher, Hassan; Dixon, Elijah (2012). "Primary Hepatic Gastrinoma Causing Zollinger-Ellison Syndrome: A Rare and Challenging Diagnosis". Cancers. 4 (4): 130–140. doi:10.3390/cancers4010130. ISSN 2072-6694.
  2. London JF, Shawker TH, Doppman JL, Frucht HH, Vinayek R, Stark HA; et al. (1991). "Zollinger-Ellison syndrome: prospective assessment of abdominal US in the localization of gastrinomas". Radiology. 178 (3): 763–7. doi:10.1148/radiology.178.3.1994415. PMID 1994415.
  3. Rösch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV, Yasuda K; et al. (1992). "Localization of pancreatic endocrine tumors by endoscopic ultrasonography". N Engl J Med. 326 (26): 1721–6. doi:10.1056/NEJM199206253262601. PMID 1317506.
  4. Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R (2001). "Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours". Ann Oncol. 12 Suppl 2: S95–9. PMID 11762360.
  5. Jensen RT (1996). "Gastrointestinal endocrine tumours. Gastrinoma". Baillieres Clin Gastroenterol. 10 (4): 603–43. PMID 9113315.

Template:WH Template:WS